We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03180957
Recruitment Status : Completed
First Posted : June 8, 2017
Last Update Posted : April 20, 2021
Department of Health, United Kingdom
Wellcome Trust
180 Therapeutics LP
Information provided by (Responsible Party):
University of Oxford

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2020
Actual Study Completion Date : December 2020
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 May 5, 2022